Sufentanil Citrate
Who holds supplier records for Sufentanil Citrate? 7 organisations hold a current record for Sufentanil Citrate: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: United States (1), United Kingdom (1), Slovakia (1), Belgium (1) and 2 other countries (2); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Sufentanil Citrate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/sufentanil-citrate
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Sufentanil Citrate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- SPECGX LLCUnited StatesCEPActive DMF 30985, 14505 · latest filing Dec 2016
- VERANOVA LPUnited KingdomActive DMF 9399 · latest filing Oct 1991
- hameln rds s.r.o.SlovakiaCEP Company GMP cert on record
- Janssen Pharmaceutica NVBelgiumCEP Company GMP cert on recordInactive DMF 11327 · latest filing Feb 1995
- SpainCEP Company GMP cert on record
- MACFARLAN SMITH LTDCEP Company GMP cert on record
- ChinaCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (6)
Certificates of Suitability on the EDQM register for Sufentanil Citrate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 8 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| YICHANG HUMANWELL PHARMACEUTICAL CO., LTD. Yichang | CN | CEP 2026-011 - Rev 00 Sufentanil citrate | Nov 2026 | Inspected Jul 2026 Hungary |
| MACFARLAN SMITH LIMITED Edinburgh | GB | CEP 2005-162 - Rev 03 Sufentanil citrate | Aug 2026 | — |
| KERN PHARMA, S.L. Terrassa | ES | CEP 2020-088 - Rev 02 Sufentanil citrate | Jun 2026 | Inspected Sept 2024 Spain |
| HAMELN RDS S.R.O. Modra | SK | CEP 2022-096 - Rev 04 Sufentanil citrate | Sept 2025 | Inspected Mar 2026 Slovakia |
| SPECGX LLC Webster Groves | US | CEP 2017-095 - Rev 01 Sufentanil citrate | May 2024 | — |
| JANSSEN PHARMACEUTICA NV Beerse | BE | R1-CEP 1998-116 - Rev 07 Sufentanil citrate | Jul 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (1)
Organisations whose Type II DMFs for Sufentanil Citrate are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- United States · Inactive DMF 26800 · filed Dec 2012
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Sufentanil Citrate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201163).
Chemical identity
- IUPAC name
- 2-hydroxypropane-1,2,3-tricarboxylic acid;N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide
- Canonical SMILES
- CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
- InChIKey
- OJCZPLDERGDQRJ-UHFFFAOYSA-N
- Synonyms
- Dsuvia, Dzuveo, R 33800, R-33800, Sufenta, Sufental, Sufentanil citrate, Sufentanil citrate cii, Sufenta preservative free, Zalviso, Fentatienil, RefChem:58797
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Opioid Agonist
- Mechanism of action
- Full Opioid Agonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Sufentanil Citrate?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Sufentanil Citrate: SPECGX LLC (United States), VERANOVA LP (United Kingdom), hameln rds s.r.o. (Slovakia), Janssen Pharmaceutica NV (Belgium), Kern Pharma, S.L. (Spain), MACFARLAN SMITH LTD and YICHANG HUMANWELL PHARMACEUTICAL CO LTD (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Sufentanil Citrate Drug Master Files are active?
SPECGX LLC (DMF 30985, 14505) and VERANOVA LP (DMF 9399). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Sufentanil Citrate records mean?
1 organisation has only inactive Type II DMFs for Sufentanil Citrate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Sufentanil Citrate have a European Certificate of Suitability?
Yes. 6 organisations hold a valid CEP for Sufentanil Citrate on the EDQM register, including YICHANG HUMANWELL PHARMACEUTICAL CO., LTD. Yichang (CN), MACFARLAN SMITH LIMITED Edinburgh (GB), KERN PHARMA, S.L. Terrassa (ES), HAMELN RDS S.R.O. Modra (SK), SPECGX LLC Webster Groves (US) and JANSSEN PHARMACEUTICA NV Beerse (BE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Sufentanil Citrate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Sufentanil Citrate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.